Delivery Order SPE2DB22D3501-SPE2DB24FWL88
Award Date
7/31/24
Potential Completion Date
8/21/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veklury (Remdesivir) 100 mg vials. The $8,851.96 firm-fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $18,725.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. It is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3103|SPE2DB24FP6V0) worth $13,618.40 for the supply of 100 mg VEKLURY (Remdesivir) vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 16, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a federal contract worth up to $1,361.84 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the antiviral drug VEKLURY (Remdesivir) in 100 mg vials. The $2,042.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $13,618.40 and a completion date of August 16, 2024. It is a firm-fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract supports the federal government's healthcare needs, likely supplying the VEKLURY medication to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 100 milligram vials of the COVID-19 treatment medication Veklury (Remdesivir) with a potential value of $13,618.40 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Veklury (100 mg vials) to the Defense Logistics Agency (DLA). The $13,618.40 firm fixed price delivery order contract has a completion date of July 1, 2024 and was awarded on June 7, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,618.40 Firm Fixed Price delivery order contract is for the supply of VEKLURY 100 MG vials, a critical pharmaceutical product. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities in...